Waverton Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-472,368
| Closed | -$32.7M | – | 76 |
|
|
2023
Q1 | $32.7M | Buy |
472,368
+65,494
| +16% | +$4.54M | 1.01% | 26 |
|
|
2022
Q4 | $29.3M | Buy |
406,874
+27,990
| +7% | +$2.01M | 1.08% | 28 |
|
|
2022
Q3 | $26.9M | Buy |
378,884
+194,634
| +106% | +$13.8M | 1.1% | 25 |
|
|
2022
Q2 | $14.2M | Buy |
184,250
+152,650
| +483% | +$11.8M | 0.55% | 33 |
|
|
2022
Q1 | $2.31M | Buy |
+31,600
| New | +$2.31M | 0.08% | 60 |
|
|
2016
Q4 | – | Sell |
-912,768
| Closed | -$49.2M | – | 111 |
|
|
2016
Q3 | $49.2M | Sell |
912,768
-18,506
| -2% | -$998K | 3.31% | 11 |
|
|
2016
Q2 | $68.5M | Buy |
931,274
+33,231
| +4% | +$2.44M | 5.14% | 3 |
|
|
2016
Q1 | $57.4M | Buy |
898,043
+119,425
| +15% | +$7.63M | 4.39% | 6 |
|
|
2015
Q4 | $53.6M | Buy |
+778,618
| New | +$53.6M | 4.03% | 6 |
|